English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/73558
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: A proteomic signature for circulating low-density granulocytes

AuthorsPavón, Esther J.; García-Rodríguez, Sonia ; Zumaquero, Esther; Perandrés-López, R.; Rosal-Vela, Antonio; Lario, Antonio; Longobardo, Victoria; Carrascal, Montserrat ; Abián, Joaquín ; Callejas-Rubio, J. L.; Ortego-Centeno, N.; Zubiaur, Mercedes; Sancho, Jaime
Issue Date2012
PublisherElsevier
CitationJournal of Proteomics 75(6): 1778-1791 (2012)
AbstractProteins differentially expressed in peripheral blood mononuclear cells (PBMCs) from systemic lupus erythematosus (SLE) patients versus Normal controls were identified by 2-DE and MALDI-MS. Thus, S100A9 expression was significantly increased in SLE PBMCs relative to Normal PBMCs at both mRNA and protein levels. Increased S100A9 levels in SLE PBMCs correlated positively with the abnormal presence of low-density granulocytes (LDGs) detected by flow-cytometry in the mononuclear cell fractions. Another set of proteins that were differentially expressed in SLE PBMCs formed S100A9-independent clusters, suggesting that these differences in protein expression are in fact reflecting changes in the abundance of specific cell types. In SLE PBMCs spots of the two S100A9 isoforms, S100A9-l and S100A9-s, and their phosphorylated counterparts were identified and confirmed to be phosphorylated at Thr 113 by MS/MS analyses. In addition, the phorbol ester PMA alone or in combination with ionomycin induced a stronger increase in threonine phosphorylation of S100A9 in SLE than in Normal PBMCs, while the same stimuli caused the opposite effect on phosphorylation and activation of Erk1/2, suggesting the existence of an abnormal S100A9 signaling in SLE PBMCs. Therefore, the expansion and activation of LDGs in SLE seems to underlie this prominent S100A9 signature. © 2011 Elsevier B.V.
URIhttp://hdl.handle.net/10261/73558
DOI10.1016/j.jprot.2011.12.020
Identifiersdoi: 10.1016/j.jprot.2011.12.020
issn: 1874-3919
Appears in Collections:(IPBLN) Artículos
(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.